aeisen's library 161 articles Export

	Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer [My Copy] J Clin Oncol (9 November 2009), JCO.2009.22.1077. by Margot Burnell, Mark N. Levine, Judith-Anne W. Chapman, et al.Vivien Bramwell, Karen Gelmon, Barbara Walley, Ted Vandenberg, Haji Chalchal, Kathy S. Albain, Edith A. Perez, Hope Rugo, Kathleen Pritchard, Patti O'Brien, Lois E. Shepherd posted to ma21 adjuvant by aeisen on 2009-11-10 16:59:25 as
	Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results [My Copy] Human Mutation, Vol. 29, No. 11. (2008), pp. 1282-1291. by Sharon E. Plon, Diana M. Eccles, Douglas Easton, et al.William D. Foulkes, Maurizio Genuardi, Marc S. Greenblatt, Frans B. L. Hogervorst, Nicoline Hoogerbrugge, Amanda B. Spurdle, Sean V. Tavtigian, for the IARC Unclassified Genetic Variants Working Group posted to vus oct_30 by aeisen on 2009-10-30 17:34:23 as
	Assessment of functional effects of unclassified genetic variants [My Copy] Human Mutation, Vol. 29, No. 11. (2008), pp. 1314-1326. by Fergus J. Couch, Lene J. Rasmussen, Robert Hofstra, et al.Alvaro N. A. Monteiro, Marc S. Greenblatt, Niels de Wind, for the IARC Unclassified Genetic Variants Working Group posted to vus oct_30 by aeisen on 2009-10-30 17:25:00 as
	International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. [My Copy] International journal of cancer. Journal international du cancer, Vol. 122, No. 9. (1 May 2008), pp. 2017-2022. by Kelly A. Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, et al.Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D. Foulkes, Jan Klijn, Eitan Friedman, Charmaine Kim-Sing, Peter Ainsworth, Barry Rosen, Susan Domchek, Teresa Wagner, Nadine Tung, Siranoush Manoukian, Fergus Couch, Ping Sun, Steven A. Narod, Hereditary Breast Cancer Clinical Study Group posted to preventive_practices oct_30 brca1_and_brca2 by aeisen on 2009-10-30 16:32:57 as along with 1 person riyad
	A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 22. (1 August 2008), pp. 3785-3790. by Alan Ashworth posted to parp oct_30 brca1_and_brca2 by aeisen on 2009-10-30 04:59:48 as along with 1 person catcremona
	Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. [My Copy] Annual review of pathology, Vol. 4 (2009), pp. 461-487. by Ashok R. Venkitaraman posted to oct_30 function brca1_and_brca2 by aeisen on 2009-10-30 04:41:00 as
	Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 30. (20 October 2009), pp. 4948-4954. by Elena F. Brachtel, Jennifer E. Rusby, James S. Michaelson, et al.Leon L. Chen, Alona Muzikansky, Barbara L. Smith, Frederick C. Koerner posted to oct_30 nipple_sparing brca1_and_brca2 by aeisen on 2009-10-30 04:14:27 as
	Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 26. (10 September 2008), pp. 4282-4288. by Deann P. Atchley, Constance T. Albarracin, Adriana Lopez, et al.Vicente Valero, Christopher I. Amos, Ana Maria M. Gonzalez-Angulo, Gabriel N. Hortobagyi, Banu K. Arun posted to pathologic_features oct_30 brca1_and_brca2 by aeisen on 2009-10-30 03:15:28 as along with 2 people and 2 groups Zephyrus songpku Breast Cancer Reading Club Roswell Cancer Crosstalk
	Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome. [My Copy] BMC cancer, Vol. 8 (14 April 2008), 101. by Larissa I. Batista, Karen H. Lu, Elisabeth K. Beahm, Banu K. Arun, Diane C. Bodurka, Funda Meric-Bernstam posted to oct_30 brca1_and_brca2 by aeisen on 2009-10-30 03:08:37 as
	Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 24, No. 16. (1 June 2006), pp. 2437-2443. by Lori J. Pierce, Albert M. Levin, Timothy R. Rebbeck, et al.Merav A. Ben-David, Eitan Friedman, Lawrence J. Solin, Eleanor E. Harris, David K. Gaffney, Bruce G. Haffty, Laura A. Dawson, Steven A. Narod, Ivo A. Olivotto, Andrea Eisen, Timothy J. Whelan, Olufunmilayo I. Olopade, Claudine Isaacs, Sofia D. Merajver, Julia S. Wong, Judy E. Garber, Barbara L. Weber posted to oct_30 brca1_and_brca2 bct by aeisen on 2009-10-30 03:03:38 as
	Selecting a BRCA risk assessment model for use in a familial cancer clinic [My Copy] BMC Medical Genetics, Vol. 9, No. 1. (22 December 2008), 116. by Seema Panchal, Marguerite Ennis, Sandra Canon, Louise Bordeleau posted to risk_assessment_models risk_assessment oct_30 brca1_and_brca2 by aeisen on 2009-10-29 03:34:59 as
	Prognosis of BRCA-associated breast cancer: a summary of evidence. [My Copy] Breast cancer research and treatment (30 September 2009) by L. Bordeleau, S. Panchal, P. Goodwin posted to prognosis oct_30 brca1_and_brca2 by aeisen on 2009-10-29 03:33:00 as
	Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 7. (1 March 2008), pp. 1093-1097. by Kelly A. Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.Henry Lynch, Charmaine Kim-Sing, Eitan Friedman, William D. Foulkes, Susan Domchek, Peter Ainsworth, Claudine Isaacs, Nadine Tung, Jacek Gronwald, Shelly Cummings, Teresa Wagner, Siranoush Manoukian, Pål Møller, Jeffrey Weitzel, Ping Sun, Steven A. Narod, Hereditary Breast Cancer Clinical Study Group posted to pm oct30 brca1_and_brca2 by aeisen on 2009-10-27 03:53:19 as
	Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation. [My Copy] British journal of cancer, Vol. 100, No. 2. (27 January 2009), pp. 421-425. by K. A. Metcalfe, A. Finch, A. Poll, et al.D. Horsman, C. Kim-Sing, J. Scott, R. Royer, P. Sun, S. A. Narod posted to breast_cancer_risk brca1_and_brca2 by aeisen on 2009-10-27 03:52:34 as
	Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. [My Copy] Lancet, Vol. 359, No. 9316. (27 April 2002), pp. 1471-1477. by Bruce G. Haffty, Elizabeth Harrold, Atif J. Khan, et al.Pradip Pathare, Tanya E. Smith, Bruce C. Turner, Peter M. Glazer, Barbara Ward, Daryl Carter, Ellen Matloff, Allen E. Bale, Mayra Alvarez-Franco posted to oct30 brca1_and_brca2 bcs by aeisen on 2009-10-27 03:48:34 as
	Is breast-conserving therapy in the genetically predisposed breast cancer patient a reasonable and appropriate option? [My Copy] European journal of cancer (Oxford, England : 1990), Vol. 40, No. 8. (May 2004), pp. 1105-1108. by B. G. Haffty, D. Lannin posted to oct30 brca1_and_brca2 bcs by aeisen on 2009-10-27 03:47:22 as
	Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. [My Copy] European journal of cancer (Oxford, England : 1990), Vol. 40, No. 8. (May 2004), pp. 1150-1158. by C. Seynaeve, L. C. Verhoog, L. M. van de Bosch, et al.A. N. van Geel, M. Menke-Pluymers, E. J. Meijers-Heijboer, A. M. van den Ouweland, A. Wagner, C. L. Creutzberg, M. F. Niermeijer, J. G. Klijn, C. T. Brekelmans posted to oct30 brca1_and_brca2 bcs by aeisen on 2009-10-27 03:46:56 as
	First case of invasive breast cancer following prophylactic bilateral skin sparing mastectomy in a BRCA1 mutation carrier. [My Copy] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, Vol. 35, No. 9. (September 2009), pp. 1016-1018. by W. Maarse, Y. Jonasse, M. G. Ausems, M. E. Schipper, R. van Hillegersberg posted to pm oct30 brca1_and_brca2 by aeisen on 2009-10-27 03:44:43 as
	Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer? [My Copy] Annals of surgical oncology (1 August 2009) by Carlos A. Garcia-Etienne, Monica Barile, Oreste D. Gentilini, et al.Edoardo Botteri, Nicole Rotmensz, Andrea Sagona, Gabriel Farante, Viviana Galimberti, Alberto Luini, Paolo Veronesi, Bernardo Bonanni posted to oct30 brca1_and_brca2 bcs by aeisen on 2009-10-27 03:43:48 as
	Are BRCA1- and BRCA2-associated breast cancers different? Prognosis of BRCA1-associated breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 18, No. 21 Suppl. (1 November 2000) by M. Robson posted to prognosis oct30 brca1_and_brca2 by aeisen on 2009-10-27 03:41:57 as
	Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. [My Copy] Journal of the National Cancer Institute, Vol. 101, No. 2. (21 January 2009), pp. 80-87. by Timothy R. Rebbeck, Noah D. Kauff, Susan M. Domchek posted to risk_reduction oct_30 brca1_and_brca2 bpo by aeisen on 2009-10-27 03:40:35 as along with 1 person merpublic
	Is breast conservation a reasonable option for women with BRCA-associated breast cancer? [My Copy] Nature clinical practice. Oncology, Vol. 4, No. 1. (January 2007), pp. 10-11. by Mark Robson posted to oct30 brca1_and_brca2 bcs by aeisen on 2009-10-27 03:39:32 as
	BRCA mutations in women with ductal carcinoma in situ. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, No. 14. (15 July 2007), pp. 4306-4310. by Karen Lisa L. Smith, Muriel Adank, Noah Kauff, et al.Kelly Lafaro, Jeff Boyd, Johanna B. Lee, Clifford Hudis, Kenneth Offit, Mark Robson posted to dcis brca1_and_brca2 by aeisen on 2009-10-27 03:38:56 as
	Estimated Risk of Radiation-Induced Breast Cancer From Mammographic Screening for Young BRCA Mutation Carriers [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 3. (4 February 2009), pp. 205-209. by Amy Berrington de Gonzalez, Christine D. Berg, Kala Visvanathan, Mark Robson posted to screening radiation_exposure oct_30 brca1_and_brca2 by aeisen on 2009-10-27 03:37:31 as
	Evaluation of a surveillance programme for women with a family history of breast cancer. [My Copy] Journal of medical genetics, Vol. 46, No. 5. (May 2009), pp. 319-323. by M. M. Reis, M. Tavakoli, J. Dewar, et al.D. Goudie, A. Cook, L. McLeish, D. Young, J. Kenyon, M. Steel posted to program_evaluation brca1_and_brca2 by aeisen on 2009-10-27 03:36:03 as
	Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. [My Copy] European journal of cancer (Oxford, England : 1990), Vol. 41, No. 15. (October 2005), pp. 2304-2311. by Youlia M. Kirova, Dominique Stoppa-Lyonnet, Alexia Savignoni, et al.Brigitte Sigal-Zafrani, Nicolas Fabre, Alain Fourquet, for the Institut Curie Breast Cancer Study Group posted to xrt oct30 brca1_and_brca2 bcs by aeisen on 2009-10-27 03:34:10 as
	Genes, cancer risks, and clinical outcomes. [My Copy] The New England journal of medicine, Vol. 357, No. 2. (12 July 2007), pp. 175-176. by Patricia Hartge posted to prognosis oct30 brca1_and_brca2 by aeisen on 2009-10-27 03:31:49 as
	Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. [My Copy] The New England journal of medicine, Vol. 357, No. 2. (12 July 2007), pp. 115-123. by Gad Rennert, Shantih Bisland-Naggan, Ofra Barnett-Griness, et al.Naomi Bar-Joseph, Shiyu Zhang, Hedy S. Rennert, Steven A. Narod posted to prognosis oct30 brca1_and_brca2 by aeisen on 2009-10-27 03:29:28 as along with 1 person jfr
	Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). [My Copy] Breast cancer research and treatment (11 August 2009) by Belinda E. Kiely, Mark A. Jenkins, Joanne M. McKinley, et al.Michael L. Friedlander, Prue Weideman, Roger L. Milne, Sue-Anne A. McLachlan, John L. Hopper, Kelly-Anne A. Phillips posted to oct30 cpm brca1_and_brca2 by aeisen on 2009-10-27 03:28:01 as
	Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment. [My Copy] Annals of surgical oncology, Vol. 15, No. 12. (December 2008), pp. 3415-3421. by Phuong L. Mai, Veronica I. Lagos, Melanie R. Palomares, Jeffrey N. Weitzel posted to oct30 cpm brca1_and_brca2 by aeisen on 2009-10-27 03:27:33 as
	Synthetic lethality--a new direction in cancer-drug development. [My Copy] The New England journal of medicine, Vol. 361, No. 2. (9 July 2009), pp. 189-191. by J. Dirk Iglehart, Daniel P. Silver posted to parp oct30 brca1_and_brca2 by aeisen on 2009-10-27 03:25:31 as
	Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. [My Copy] The New England journal of medicine, Vol. 361, No. 2. (9 July 2009), pp. 123-134. by Peter C. Fong, David S. Boss, Timothy A. Yap, et al.Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J. O'Connor, Alan Ashworth, James Carmichael, Stan B. Kaye, Jan H. Schellens, Johann S. de Bono posted to parp oct30 brca1_and_brca2 by aeisen on 2009-10-27 03:24:27 as along with 1 person frohike
	Targeting the molecular defect in BRCA-deficient tumors for cancer therapy. [My Copy] Cancer cell, Vol. 16, No. 2. (4 August 2009), pp. 89-90. by Ashok R. Venkitaraman posted to parp oct30 brca1_and_brca2 by aeisen on 2009-10-27 03:23:38 as
	The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women After Prophylactic Salpingo-Oophorectomy [My Copy] J Clin Oncol, Vol. 24, No. 22. (1 August 2006), pp. 3576-3582. by Joanna B. Madalinska, Marc van Beurden, Eveline M. A. Bleiker, et al.Heiddis B. Valdimarsdottir, Judith Hollenstein, Leon F. Massuger, Katja N. Gaarenstroom, Marian J. E. Mourits, Rene H. M. Verheijen, Eleonora B. L. van Dorst, Hans van der Putten, Ko van der Velden, Henk Boonstra, Neil K. Aaronson posted to cbcf_oct09 bpo_adverse_effects bpo by aeisen on 2009-10-23 16:38:09 as
	Prophylactic oophorectomy in premenopausal women and long-term health. [My Copy] Menopause international, Vol. 14, No. 3. (September 2008), pp. 111-116. by Lynne T. Shuster, Bobbie S. Gostout, Brandon R. Grossardt, Walter A. Rocca posted to po by aeisen on 2009-10-23 16:34:48 as
	Utilization of Screening and Preventive Surgery Among Unaffected Carriers of a BRCA1 or BRCA2 Gene Mutation [My Copy] Cancer Epidemiology Biomarkers & Prevention, Vol. 13, No. 12. (December 2004), pp. 1989-1995. by Sara Wainberg, Janice Husted posted to pm brca1_and_brca2 bpo by aeisen on 2009-10-23 15:22:13 as
	Risk-reduction surgery decisions in high-risk women seen for genetic counseling. [My Copy] Journal of genetic counseling, Vol. 14, No. 6. (December 2005), pp. 473-484. by Jessica A. Ray, Lois J. Loescher, Molly Brewer posted to cbcf_oct09 bpo_uptake by aeisen on 2009-10-23 15:16:08 as
	Commentary: Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era? [My Copy] The oncologist (9 October 2009) by Kathleen I. Pritchard posted to adjuvant by aeisen on 2009-10-23 15:09:01 as
	Prospective breast cancer risk prediction model for women undergoing screening mammography. [My Copy] Journal of the National Cancer Institute, Vol. 98, No. 17. (6 September 2006), pp. 1204-1214. by William E. Barlow, Emily White, Rachel Ballard-Barbash, et al.Pamela M. Vacek, Linda Titus-Ernstoff, Patricia A. Carney, Jeffrey A. Tice, Diana S. Buist, Berta M. Geller, Robert Rosenberg, Bonnie C. Yankaskas, Karla Kerlikowske posted to screening_mammogram risk_prediction risk_assessment_models by aeisen on 2009-10-22 06:15:42 as
	Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. [My Copy] Lancet, Vol. 350, No. 9084. (11 October 1997), pp. 1047-1059. posted to hrt by aeisen on 2009-10-22 06:07:28 as
	Effect of screening and adjuvant therapy on mortality from breast cancer. [My Copy] The New England journal of medicine, Vol. 353, No. 17. (27 October 2005), pp. 1784-1792. by Donald A. Berry, Kathleen A. Cronin, Sylvia K. Plevritis, et al.Dennis G. Fryback, Lauren Clarke, Marvin Zelen, Jeanne S. Mandelblatt, Andrei Y. Yakovlev, J. Dik Habbema, Eric J. Feuer, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators posted to cbcf_oct09 breast_cancer_mortality by aeisen on 2009-10-21 17:22:54 as
	Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics [My Copy] J Med Genet, Vol. 45, No. 7. (1 July 2008), pp. 425-431. by A. C. Antoniou, R. Hardy, L. Walker, et al.D. G. Evans, A. Shenton, R. Eeles, S. Shanley, G. Pichert, L. Izatt, S. Rose, F. Douglas, D. Eccles, P. J. Morrison, J. Scott, R. L. Zimmern, D. F. Easton, P. D. P. Pharoah posted to risk_assessment_models cbcf_oct09 brca1_and_brca2 by aeisen on 2009-10-21 17:14:10 as
	Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17 beta and progesterone in postmenopausal women. [My Copy] Gynecologic and obstetric investigation, Vol. 27, No. 4. (1989), pp. 204-207. by H. Pschera, A. Hjerpe, K. Carlström posted to vaginal-estrogen cbcf_oct09 by aeisen on 2009-10-21 06:47:42 as
	Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. [My Copy] Lancet, Vol. 349, No. 9064. (24 May 1997), pp. 1505-1510. posted to pathology cbcf_oct09 brca1_and_brca2 by aeisen on 2009-10-21 06:42:20 as
	Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation. [My Copy] Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC, Vol. 29, No. 1. (January 2007), pp. 45-60. by Doug Horsman, Brenda J. Wilson, Denise Avard, et al.Wendy S. Meschino, Charmaine Kim Sing, Marie Plante, Andrea Eisen, Heather E. Howley, Jacques Simard, National Hereditary Cancer Task Force posted to guideline cbcf_oct09 brca1_and_brca2 by aeisen on 2009-10-21 06:33:54 as
	Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 19. (1 October 2008), pp. 1361-1367. by Andrea Eisen, Jan Lubinski, Jacek Gronwald, et al.Pal Moller, Henry T. Lynch, Jan Klijn, Charmaine Kim-Sing, Susan L. Neuhausen, Lucy Gilbert, Parviz Ghadirian, Siranoush Manoukian, Gad Rennert, Eitan Friedman, Claudine Isaacs, Eliot Rosen, Barry Rosen, Mary Daly, Ping Sun, Steven A. Narod, Hereditary Breast Cancer Clinical Study Group posted to hrt cbcf_oct09 brca1_and_brca2 by aeisen on 2009-10-21 06:32:18 as along with 2 people and 2 groups merpublic songpku Roswell Cancer Crosstalk Breast Cancer Reading Club
	Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. [My Copy] American journal of human genetics, Vol. 72, No. 5. (May 2003), pp. 1117-1130. by A. Antoniou, P. D. Pharoah, S. Narod, et al.H. A. Risch, J. E. Eyfjord, J. L. Hopper, N. Loman, H. Olsson, O. Johannsson, A. Borg, B. Pasini, P. Radice, S. Manoukian, D. M. Eccles, N. Tang, E. Olah, H. Anton-Culver, E. Warner, J. Lubinski, J. Gronwald, B. Gorski, H. Tulinius, S. Thorlacius, H. Eerola, H. Nevanlinna, K. Syrjäkoski, O-P P. Kallioniemi, D. Thompson, C. Evans, J. Peto, F. Lalloo, D. G. Evans, D. F. Easton posted to penetrance cbcf_oct09 brca1_and_brca2 by aeisen on 2009-10-21 06:28:39 as along with 1 person Zephyrus
	Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. [My Copy] Journal of medical genetics, Vol. 42, No. 7. (July 2005), pp. 602-603. by A. C. Antoniou, P. D. Pharoah, S. Narod, et al.H. A. Risch, J. E. Eyfjord, J. L. Hopper, H. Olsson, O. Johannsson, A. Borg, B. Pasini, P. Radice, S. Manoukian, D. M. Eccles, N. Tang, E. Olah, H. Anton-Culver, E. Warner, J. Lubinski, J. Gronwald, B. Gorski, H. Tulinius, S. Thorlacius, H. Eerola, H. Nevanlinna, K. Syrjäkoski, O-P P. Kallioniemi, D. Thompson, C. Evans, J. Peto, F. Lalloo, D. G. Evans, D. F. Easton posted to penetrance cbcf_oct09 brca1_and_brca2 by aeisen on 2009-10-21 06:27:23 as along with 1 person Zephyrus
	Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer [My Copy] N Engl J Med, Vol. 358, No. 26. (26 June 2008), pp. 2796-2803. by Paul D. P. Pharoah, Antonis C. Antoniou, Douglas F. Easton, Bruce A. J. Ponder posted to susceptibility_alleles risk_for_breast_cancer penetrance cbcf_oct09 by aeisen on 2009-10-21 06:15:16 as along with 5 people and 2 groups Zephyrus misonneh songpku guhjy balicea Roswell Cancer Crosstalk Breast Cancer Reading Club
	The Risk of Cancer Risk Prediction: "What Is My Risk of Getting Breast Cancer?" [My Copy] J. Natl. Cancer Inst., Vol. 98, No. 23. (6 December 2006), pp. 1673-1675. by Joann G. Elmore, Suzanne W. Fletcher posted to risk_prediction risk_assessment_tool risk_assessment_models by aeisen on 2009-10-21 06:11:06 as

Note: You may cite this page as: http://www.citeulike.org/user/aeisen

Result page: 1 2 3 4 Next

brca1_and_brca2	39
cbcf_oct09	27
smoking_cessation	19
oct30	16
oct_30	13
sept30	13
gtaprop	12
hrt	9
testicular_cancer	9
risk_perception	8
bcs	6
risk_assessment_models	6
smoke-free	6
adjuvant	5
risk_assessment	5
health_literacy	4
literacy	4
parp	4
prognosis	4
risk_assessment_tool	4
bpo	3
breast_cancer_risk	3
cancer_prevention	3
penetrance	3
pm	3
prevention	3
vaginal-estrogen	3
bisphosphonate	2
bladder	2
cpm	2
education	2
guideline	2
knowledge	2
literature	2
met_brca	2
risk_prediction	2
survivorship	2
vus	2
zometa	2
aromatase_inhibitor	1
aromatase_inhibitors	1
avastin	1
bcpt	1
bct	1
bevicizumab	1
bpo_adverse_effects	1
bpo_uptake	1
brca1_and_brca2_genes	1
brca2	1
breast_cancer_mortality	1
breast_cancer_survivors	1
cancer_risk_assessment	1
dcis	1
decision_aid	1
e2100	1
estrogen	1
family_history_collection	1
fgfr1	1
function	1
gcsf	1
gemcitabine	1
genetic_risk_assessment	1
her2	1
ihc	1
ma21	1
map3	1
nipple_sparing	1
nonadherence	1
paclitaxel	1
pathologic_features	1
pathology	1
patient_education	1
plasma_levels_estrogen	1
po	1
premature_menopause	1
preventive_practices	1
program_evaluation	1
radiation_exposure	1
realm	1
risk_factors_for_breast_cancer	1
risk_for_breast_cancer	1
risk_reduction	1
screening	1
screening_interventions	1
screening_mammogram	1
star_trial	1
susceptibility_alleles	1
xrt	1

aeisen's library 161 articles Export

aeisen's tags